Elizabeth J Goldsmith

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Top Venues

Drug design, development and therapy

ACS medicinal chemistry letters

bioRxiv : the preprint server for biology

This page only lists publications with an associated author ORCID identifier.

Publications

Liliana R Teixeira, Radha Akella, John M Humphreys, Haixia He, Elizabeth J Goldsmith
Water and chloride as allosteric inhibitors in WNK kinase osmosensing. bioRxiv : the preprint server for biology (2023)
Julita Chlebowicz, Radha Akella, John M Humphreys, Haixia He, Ashari R Kannangara, Shuguang Wei, Bruce A Posner, Elizabeth J Goldsmith
Identification of a Class of WNK Isoform-Specific Inhibitors Through High-Throughput Screening. Drug design, development and therapy 17 (2023)
Julita Chlebowicz, Radha Akella, John M Humphreys, Haixia He, Ashari R Kannangara, Shuguang Wei, Bruce A Posner, Elizabeth J Goldsmith
Identification of a Class of WNK Isoform-Specific Inhibitors Through High-Throughput Screening. Drug design, development and therapy 17 (2023)
Julita Chlebowicz, Radha Akella, John M Humphreys, Haixia He, Ashari R Kannangara, Shuguang Wei, Bruce A Posner, Elizabeth J Goldsmith
Identification of a Class of WNK Isoform-Specific Inhibitors Through High-Throughput Screening. Drug design, development and therapy 17 (2023)
Melanie Rodriguez, Ashari Kannangara, Julita Chlebowicz, Radha Akella, Haixia He, Uttam K Tambar, Elizabeth J Goldsmith
Synthesis and Structural Characterization of Novel Trihalo-sulfone Inhibitors of WNK1. ACS medicinal chemistry letters 13 (10) (2022)
Radha Akella, Mateusz A Drozdz, John M Humphreys, Jenny Jiou, Mateusz Z Durbacz, Zuhair J Mohammed, Haixia He, Joanna Liwocha, Kamil Sekulski, Elizabeth J Goldsmith
A Phosphorylated Intermediate in the Activation of WNK Kinases. Biochemistry 59 (18) (2020)